We are live on ! Find out more
IMGO

Imago BioSciences, Inc. Common stock
IMGO

Delisted

IMGO was delisted on the 10th of January, 2023.

Back to rankings

106 hedge funds and large institutions have $1.05B invested in Imago BioSciences, Inc. Common stock in 2022 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

273% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 15

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

120% more capital invested

Capital invested by funds: $478M → $1.05B (+$576M)

63% more funds holding

Funds holding: 65 → 106 (+41)

39% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 18

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $910K

Holders
106
Holders Change
+41
Holders Change %
+63.08%
% of All Funds
1.7%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.08%
New
56
Increased
25
Reduced
18
Closed
15
Calls
–
Puts
$910K
Net Calls
-$910K
Net Calls Change
-$910K

Top Buyers

Rank Fund Capital Flow
1
FLSM
Frazier Life Sciences Management
California
+$25.4M
2
VI
Versor Investments
New York
+$25.1M
3
TAL
TIG Advisors LLC
New York
+$24.8M
4
AAM
Alpine Associates Management
Florida
+$24.4M
5
MF
Magnetar Financial
Illinois
+$18.2M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$127M
2
Citadel Advisors
Citadel Advisors
Florida
-$59.2M
3
FCM
Farallon Capital Management
California
-$37.2M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$28.4M
5
EA
Emerald Advisers
Pennsylvania
-$12.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
E
26
Ergoteles
New York
$8.46M +$5.89M +235,442 New
WIC
27
Water Island Capital
New York
$8.4M +$5.84M +233,522 New
Qube Research & Technologies (QRT)
28
Qube Research & Technologies (QRT)
United Kingdom
$8.39M +$5.84M +233,481 New
Adage Capital Partners
29
Adage Capital Partners
Massachusetts
$8.09M +$625K +25,000 +13%
UBS Group
30
UBS Group
Switzerland
$6.71M +$4.63M +185,064 +12,496%
GCIA
31
Gabelli & Co Investment Advisers
New York
$6.06M +$4.22M +168,600 New
PCM
32
Prelude Capital Management
New York
$6.02M +$4.18M +167,339 New
Millennium Management
33
Millennium Management
New York
$4.59M +$3.19M +127,773 New
AllianceBernstein
34
AllianceBernstein
Tennessee
$4.48M +$3.12M +124,657 New
Fidelity International
35
Fidelity International
Bermuda
$4.31M +$3M +120,000 New
SCM
36
Soleus Capital Management
Connecticut
$4.13M -$2.45M -98,000 -46%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$3.6M +$577K +23,092 +30%
N
38
Nuveen
North Carolina
$3.51M -$138K -5,521 -5%
Citadel Advisors
39
Citadel Advisors
Florida
$3.5M -$59.2M -2,367,410 -96%
CS
40
Credit Suisse
Switzerland
$3.1M +$1.93M +77,173 +857%
KC
41
Kellner Capital
New York
$2.96M +$2.06M +82,200 New
Renaissance Technologies
42
Renaissance Technologies
New York
$2.92M +$2.03M +81,300 New
Charles Schwab
43
Charles Schwab
California
$2.52M +$36.7K +1,467 +2%
Bank of America
44
Bank of America
North Carolina
$2.22M +$1.43M +56,995 +1,220%
FSI
45
Flow State Investments
Illinois
$2M +$1.39M +55,512 New
SAM
46
Silphium Asset Management
United Kingdom
$1.8M +$1.25M +50,000 New
CS
47
Candriam SCA
Luxembourg
$1.73M +$1.2M +48,094 New
GI
48
GAMCO Investors
Connecticut
$1.66M +$1.15M +46,169 New
WAM
49
Wolverine Asset Management
Illinois
$1.65M +$1.15M +45,958 New
KCM
50
Kennedy Capital Management
Missouri
$1.64M -$15.6K -625 -1%
1
2
3 4 5

IMGO Hedge Fund Activity: Q4 2022 in Review

106 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Imago BioSciences, Inc. Common stock (IMGO) for Q4 2022, worth a combined $1.05B — up 120% from $478M a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new IMGO positions and 15 closed out — a net gain of 41 holders — while 25 added to existing stakes and 18 trimmed.

The largest buyer was Frazier Life Sciences Management, adding an estimated $25.4M. The largest seller was Fidelity Investments, cutting an estimated $127M.

  • 106 institutional investors held Imago BioSciences, Inc. Common stock (IMGO) as of Q4 2022, up from 65 in Q3 2022.
  • Funds reported $1.05B of Imago BioSciences, Inc. Common stock stock for Q4 2022, up 120% quarter-over-quarter.
  • 56 funds opened new Imago BioSciences, Inc. Common stock positions in Q4 2022 and 15 closed out, a net change of +41 holders.
  • The largest Imago BioSciences, Inc. Common stock buyer in Q4 2022 was Frazier Life Sciences Management, an estimated $25.4M added.
  • The largest Imago BioSciences, Inc. Common stock seller in Q4 2022 was Fidelity Investments, an estimated $127M sold.

Based on aggregated 13F filings for Q4 2022.